Akums Drugs shares rose sharply on Monday to hit a 52-week high after the company reported strong Q1 FY27 results. Revenue rose 13.9% year-on-year, while profit increased 55%. EBITDA grew 35.4%, supported by strong performance in its CDMO business. The stock has gained 67% so far this year.
Akums Drugs shares rose sharply on Monday to hit a 52-week high after the company reported strong Q1 FY27 results. Revenue rose 13.9% year-on-year, while profit increased 55%. EBITDA grew 35.4%, supported by strong performance in its CDMO business. The stock has gained 67% so far this year.
<iframe src="https://hindustansphere.com/embed/cluster/2a43d3bb630092fcf68db2032a83ae0c0d4d42fe" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Akums Drugs shares rally 9% hit 52-week high after Q1 results; stock up 67% YTD"></iframe>
